Katherine Arline Email and Phone Number
Katherine Arline work email
- Valid
- Valid
- Valid
- Valid
- Valid
Katherine Arline personal email
Katherine Arline phone numbers
At KHORA, I drive the development of DELVE, our computational platform that leverages novel algorithms, deep learning, bioinformatics, statistics, and other tools to gather new insights about cancer in days, not decades. Using DELVE, including our proprietary transcriptional-based algorithm GCVA, we match patients with therapies from which they may benefit regardless of mutational status, and help position their new and existing therapies in over 160 distinct cancers.
-
Co-Founder And Chief Technology OfficerKhora Therapeutics Sep 2024 - PresentKhora Therapeutics is a next-generation biopharma company harnessing the power of advanced computation, comprehensive multi-omics, and asset portfolio optimization techniques to create a new era in global drug development. Our focus is on clinical-stage precision oncology assets with a particular emphasis on bringing transformative therapies to highest-need patients around the world.
-
Co-Founder And Chief Technology OfficerShepherd Health Jan 2024 - Sep 2024SHEPHERD believes cancer is an infinitely complex problem - unsolvable with traditional science. The reality is that any therapeutic has a full suite of activity across the entire multi-omic profile of a patient. Our answer is a multi-omic platform focused on the mathematical interrogation of pan-indication, therapeutic impact on gene expression, called DELVE, which can capture the full biological impact of any drug on any patient. The result? The highest-potential personalized drug recommendations that medicine can offer enabling defiantly democratic access to world class medicine for any patient anywhere.SHEPHERD also applies the platform to drug development in partnership with biopharma companies across therapeutic modalities. SHEPHERD identifies the full multi-omic impact signature of a therapeutic and the characteristics necessary for it’s maximum therapeutic efficacy and durability. The result is a pan-indication, patient by patient prediction of whether a therapeutic will work for a specific patient or not and to what degree.SHEPHERD dreams of a world in which every patient, from the hospitals of Brooklyn to the villages of Ethiopia, regardless of race, religion, creed, gender, socioeconomic status, or geographical location is given the optimum care most likely to afford them a fighting chance to LIVE for decades not days.There is ALWAYS Hope. It LIVES at SHEPHERD. -
Chief Strategy OfficerShepherd Therapeutics Jan 2017 - Dec 2023Boston, Massachusetts, Us -
Co-Founder And CeoVasanta Health, Llc Jun 2015 - Jan 2017
-
Research AssistantHarvard University Oct 2014 - May 2016Cambridge, Massachusetts, UsResearch assistant for "The Death of Expertise" by Professor Tom Nichols of Harvard University and the U.S. Naval War College. -
PrincipalKatherine Arline Design 2003 - Jun 2015I have worked with hundreds of companies and individuals to create unique, dynamic websites that express each company's unique vision while taking advantage of the latest web technology. I have extensive experience with technologies including HTML5, jQuery, D3, CSS, responsive development, Wordpress and Expression Engine. As a designer, I take pride in creating beautiful and unique designs that express the passion and drive of each business.
-
Freelance Writer Covering Finance, Security, And TechnologyFreelance Writer Aug 2013 - May 2015I've been excited to return to my roots (albeit part-time) as a writer and editor over the last two years. I specialize in technology and financial topics, and have a special interest in security and business development. I have contributed dozens of pieces to publications including Business News Daily.
-
Research AssistantHarvard University Feb 2013 - May 2013Cambridge, Massachusetts, UsCompleted a project researching congressional history with Professor Robert Allison.
-
PublisherWind River Press 1999 - 2008As the owner and publisher of Wind River Press, I oversaw our three publications: the literary magazine The Paumanok Review, the book review Critique, and the full-length imprint Wind River Press. Among many outstanding pieces published in Critique and its yearly special edition "On Writing" were essays by and interviews with Nobel and Pulitzer prize winners including Umberto Eco, as well as fan-favorites such as Dean Koontz. It was an honor to work with so many talented writers and co-editors, and truly one of the special highlights of my career.
Katherine Arline Skills
Katherine Arline Education Details
-
Harvard UniversityBioinformatics -
Harvard UniversityEconomics
Frequently Asked Questions about Katherine Arline
What company does Katherine Arline work for?
Katherine Arline works for Khora Therapeutics
What is Katherine Arline's role at the current company?
Katherine Arline's current role is Co-Founder and Chief Technology Officer at KHORA Therapeutics.
What is Katherine Arline's email address?
Katherine Arline's email address is ka****@****lth.com
What is Katherine Arline's direct phone number?
Katherine Arline's direct phone number is +171729*****
What schools did Katherine Arline attend?
Katherine Arline attended Harvard University, Harvard University.
What skills is Katherine Arline known for?
Katherine Arline has skills like Social Media, Graphic Design, Advertising, Editing, Research, Web Design, User Interface Design, Wordpress, Adobe Creative Suite, Social Media Marketing, Marketing Communications, Online Marketing.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial